Ridgepost Capital Inc. <RPC.N>: Oppenheimer cuts target price to $15 from $16
RPC•Related News
FibroBiologics ships third CYWC628 batch to Australia for Phase 1/2 diabetic foot ulcer trial
FBLG•
Laser Photonics says Laser Shield anti-drone system neutralizes simulated Class I drone in under three seconds during live test
LASE•
Sportradar expands Polymarket partnership to cover 20-plus global sports leagues and competitions
SRAD•
LogProstyle Inc. Enters Into Agreement To Acquire 100% Of I-FLATZ Corporation
LGPS•
Edible Garden wins expanded Target fresh herb program for holiday season
EDBL•